Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors is the investment advisory entity affiliated with Atlas Venture, a Boston-based venture capital firm established in 1980. The firm has raised multiple funds focused on life sciences, with Atlas Venture Fund XIII closing at $450 million in 2021 (per the firm, 2021). The advisors focus on early-stage biotechnology and pharmaceutical investments, targeting therapeutics, drug discovery platforms, and medical technologies. They typically lead or co-lead Series A rounds and participate in follow-on financings. Portfolio companies include numerous publicly traded firms such as Editas Medicine, Agios Pharmaceuticals, and Blueprint Medicines, alongside private ventures like Vor Biopharma and Recludix Pharma (per company announcements, various years). Geographic focus is primarily North America, with some activity in Europe. The firm employs a team of investment professionals with scientific and financial backgrounds, though the exact headcount is not publicly disclosed. Atlas Venture does not maintain additional offices outside its Boston headquarters. The affiliated Atlas Venture Foundation supports life sciences education and research, but is structurally separate from the advisory activities. What distinguishes Atlas Venture Life Science Advisors is its deep integration with Atlas Venture's full-cycle venture capital platform. The advisors benefit from the firm's multidecade track record, extensive network of scientific advisors, and access to proprietary deal flow generated through Atlas Venture's direct investing activities. This structure allows the advisors to operate with domain-specific expertise that is rare among generalist advisory firms.